Annual Drug Patent Expirations for REZDIFFRA
Rezdiffra is a drug marketed by Madrigal and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has ninety-seven patent family members in thirty-four countries.
The generic ingredient in REZDIFFRA is resmetirom. One supplier is listed for this compound. Additional details are available on the resmetirom profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
